Cargando…
Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017
BACKGROUND: Substance use is common among people living with HIV and has been associated with suboptimal HIV treatment outcomes. Integrating substance use services into HIV care is a promising strategy to improve patient outcomes. METHODS: We report on substance use education, screening, and referra...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451518/ https://www.ncbi.nlm.nih.gov/pubmed/32853246 http://dx.doi.org/10.1371/journal.pone.0237772 |
_version_ | 1783574994126635008 |
---|---|
author | Parcesepe, Angela M. Lancaster, Kathryn Edelman, E. Jennifer DeBoni, Raquel Ross, Jeremy Atwoli, Lukoye Tlali, Mpho Althoff, Keri Tine, Judicaël Duda, Stephany N. Wester, C. William Nash, Denis |
author_facet | Parcesepe, Angela M. Lancaster, Kathryn Edelman, E. Jennifer DeBoni, Raquel Ross, Jeremy Atwoli, Lukoye Tlali, Mpho Althoff, Keri Tine, Judicaël Duda, Stephany N. Wester, C. William Nash, Denis |
author_sort | Parcesepe, Angela M. |
collection | PubMed |
description | BACKGROUND: Substance use is common among people living with HIV and has been associated with suboptimal HIV treatment outcomes. Integrating substance use services into HIV care is a promising strategy to improve patient outcomes. METHODS: We report on substance use education, screening, and referral practices from two surveys of HIV care and treatment sites participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium. HIV care and treatment sites participating in IeDEA are primarily public-sector health facilities and include both academic and community-based hospitals and health facilities. A total of 286 sites in 45 countries participated in the 2014–2015 survey and 237 sites in 44 countries participated in the 2017 survey. We compared changes over time for 147 sites that participated in both surveys. RESULTS: In 2014–2015, most sites (75%) reported providing substance use-related education on-site (i.e., at the HIV clinic or the same health facility). Approximately half reported on-site screening for substance use (52%) or referrals for substance use treatment (51%). In 2017, the proportion of sites providing on-site substance use-related education, screening, or referrals increased by 9%, 16%, and 8%, respectively. In 2017, on-site substance use screening and referral were most commonly reported at sites serving only adults (compared to only children/adolescents or adults and children/adolescents; screening: 86%, 37%, and 59%, respectively; referral: 76%, 47%, and 46%, respectively) and at sites in high-income countries (compared to upper middle income, lower middle income or low-income countries; screening: 89%, 76%, 68%, and 45%, respectively; referral: 82%, 71%, 57%, and 34%, respectively). CONCLUSION: Although there have been increases in the proportion of sites reporting substance use education, screening, and referral services across IeDEA sites, gaps persist in the integration of substance use services into HIV care, particularly in relation to screening and referral practices, with reduced availability for children/adolescents and those receiving care within resource-constrained settings. |
format | Online Article Text |
id | pubmed-7451518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-74515182020-09-02 Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017 Parcesepe, Angela M. Lancaster, Kathryn Edelman, E. Jennifer DeBoni, Raquel Ross, Jeremy Atwoli, Lukoye Tlali, Mpho Althoff, Keri Tine, Judicaël Duda, Stephany N. Wester, C. William Nash, Denis PLoS One Research Article BACKGROUND: Substance use is common among people living with HIV and has been associated with suboptimal HIV treatment outcomes. Integrating substance use services into HIV care is a promising strategy to improve patient outcomes. METHODS: We report on substance use education, screening, and referral practices from two surveys of HIV care and treatment sites participating in the International epidemiology Databases to Evaluate AIDS (IeDEA) consortium. HIV care and treatment sites participating in IeDEA are primarily public-sector health facilities and include both academic and community-based hospitals and health facilities. A total of 286 sites in 45 countries participated in the 2014–2015 survey and 237 sites in 44 countries participated in the 2017 survey. We compared changes over time for 147 sites that participated in both surveys. RESULTS: In 2014–2015, most sites (75%) reported providing substance use-related education on-site (i.e., at the HIV clinic or the same health facility). Approximately half reported on-site screening for substance use (52%) or referrals for substance use treatment (51%). In 2017, the proportion of sites providing on-site substance use-related education, screening, or referrals increased by 9%, 16%, and 8%, respectively. In 2017, on-site substance use screening and referral were most commonly reported at sites serving only adults (compared to only children/adolescents or adults and children/adolescents; screening: 86%, 37%, and 59%, respectively; referral: 76%, 47%, and 46%, respectively) and at sites in high-income countries (compared to upper middle income, lower middle income or low-income countries; screening: 89%, 76%, 68%, and 45%, respectively; referral: 82%, 71%, 57%, and 34%, respectively). CONCLUSION: Although there have been increases in the proportion of sites reporting substance use education, screening, and referral services across IeDEA sites, gaps persist in the integration of substance use services into HIV care, particularly in relation to screening and referral practices, with reduced availability for children/adolescents and those receiving care within resource-constrained settings. Public Library of Science 2020-08-27 /pmc/articles/PMC7451518/ /pubmed/32853246 http://dx.doi.org/10.1371/journal.pone.0237772 Text en © 2020 Parcesepe et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Parcesepe, Angela M. Lancaster, Kathryn Edelman, E. Jennifer DeBoni, Raquel Ross, Jeremy Atwoli, Lukoye Tlali, Mpho Althoff, Keri Tine, Judicaël Duda, Stephany N. Wester, C. William Nash, Denis Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017 |
title | Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017 |
title_full | Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017 |
title_fullStr | Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017 |
title_full_unstemmed | Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017 |
title_short | Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017 |
title_sort | substance use service availability in hiv treatment programs: data from the global iedea consortium, 2014-2015 and 2017 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7451518/ https://www.ncbi.nlm.nih.gov/pubmed/32853246 http://dx.doi.org/10.1371/journal.pone.0237772 |
work_keys_str_mv | AT parcesepeangelam substanceuseserviceavailabilityinhivtreatmentprogramsdatafromtheglobaliedeaconsortium20142015and2017 AT lancasterkathryn substanceuseserviceavailabilityinhivtreatmentprogramsdatafromtheglobaliedeaconsortium20142015and2017 AT edelmanejennifer substanceuseserviceavailabilityinhivtreatmentprogramsdatafromtheglobaliedeaconsortium20142015and2017 AT deboniraquel substanceuseserviceavailabilityinhivtreatmentprogramsdatafromtheglobaliedeaconsortium20142015and2017 AT rossjeremy substanceuseserviceavailabilityinhivtreatmentprogramsdatafromtheglobaliedeaconsortium20142015and2017 AT atwolilukoye substanceuseserviceavailabilityinhivtreatmentprogramsdatafromtheglobaliedeaconsortium20142015and2017 AT tlalimpho substanceuseserviceavailabilityinhivtreatmentprogramsdatafromtheglobaliedeaconsortium20142015and2017 AT althoffkeri substanceuseserviceavailabilityinhivtreatmentprogramsdatafromtheglobaliedeaconsortium20142015and2017 AT tinejudicael substanceuseserviceavailabilityinhivtreatmentprogramsdatafromtheglobaliedeaconsortium20142015and2017 AT dudastephanyn substanceuseserviceavailabilityinhivtreatmentprogramsdatafromtheglobaliedeaconsortium20142015and2017 AT westercwilliam substanceuseserviceavailabilityinhivtreatmentprogramsdatafromtheglobaliedeaconsortium20142015and2017 AT nashdenis substanceuseserviceavailabilityinhivtreatmentprogramsdatafromtheglobaliedeaconsortium20142015and2017 AT substanceuseserviceavailabilityinhivtreatmentprogramsdatafromtheglobaliedeaconsortium20142015and2017 |